Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	May 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Mar 31, 2022	Mar 31, 2021
Market Capitalization	303	363	469	871	501	434
Market Cap Growth	-22.48%	-22.48%	-46.17%	73.82%	15.35%	26.25%
Enterprise Value	339	358	380	787	493	311
Last Close Price	0.14	0.17	0.21	0.39	0.21	0.18
Forward PE	-	6.55	6.55	6.55	6.55	6.55
PS Ratio	0.92	1.10	0.88	1.59	0.98	0.92
PB Ratio	0.60	0.72	0.79	1.33	0.64	0.55
P/TBV Ratio	0.78	0.94	0.95	1.64	0.79	0.69
P/FCF Ratio	-	-	-	12.69	-	-
P/OCF Ratio	-	-	-	8.55	-	-
EV/Sales Ratio	1.03	1.09	0.71	1.44	0.97	0.66
EV/FCF Ratio	-11.17	-	-	11.47	-	-
Debt / Equity Ratio	0.25	0.25	0.19	0.22	0.20	0.18
Debt / EBITDA Ratio	-	-	20.85	-	-	-
Debt / FCF Ratio	-	-	-	2.06	-	-
Asset Turnover	0.39	0.39	0.53	-	0.44	0.46
Inventory Turnover	3.38	3.38	4.88	-	3.86	3.82
Quick Ratio	0.69	0.69	0.89	1.40	1.83	1.80
Current Ratio	0.86	0.86	1.10	1.54	2.13	2.83
Return on Equity (ROE)	-11.19%	-11.19%	-4.01%	-	-2.74%	-3.34%
Return on Assets (ROA)	-4.02%	-4.02%	-1.81%	-	-2.40%	-2.08%
Return on Capital (ROIC)	-5.06%	-5.06%	-2.42%	-	-2.92%	-2.50%
Earnings Yield	-20.24%	-16.89%	-5.15%	-6.27%	-3.95%	-6.25%
FCF Yield	-10.00%	-8.34%	-21.13%	7.88%	-12.37%	-42.21%
Dividend Yield	3.47%	-	1.22%	0.89%	1.21%	1.42%
Total Shareholder Return	3.47%	-	1.22%	0.89%	1.21%	1.42%

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.